These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30458163)

  • 41. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.
    Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A
    Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease.
    Ognibene E; Middei S; Daniele S; Adriani W; Ghirardi O; Caprioli A; Laviola G
    Behav Brain Res; 2005 Jan; 156(2):225-32. PubMed ID: 15582108
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intracerebroventricular injection of beta-amyloid in mice is associated with long-term cognitive impairment in the modified hole-board test.
    Schmid S; Jungwirth B; Gehlert V; Blobner M; Schneider G; Kratzer S; Kellermann K; Rammes G
    Behav Brain Res; 2017 May; 324():15-20. PubMed ID: 28193522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heparan sulfate subdomains that are degraded by Sulf accumulate in cerebral amyloid ß plaques of Alzheimer's disease: evidence from mouse models and patients.
    Hosono-Fukao T; Ohtake-Niimi S; Hoshino H; Britschgi M; Akatsu H; Hossain MM; Nishitsuji K; van Kuppevelt TH; Kimata K; Michikawa M; Wyss-Coray T; Uchimura K
    Am J Pathol; 2012 May; 180(5):2056-67. PubMed ID: 22429964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology.
    Leal MC; Dorfman VB; Gamba AF; Frangione B; Wisniewski T; Castaño EM; Sigurdsson EM; Morelli L
    J Neuropathol Exp Neurol; 2006 Oct; 65(10):976-87. PubMed ID: 17021402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction in open field activity in the absence of memory deficits in the App
    Whyte LS; Hemsley KM; Lau AA; Hassiotis S; Saito T; Saido TC; Hopwood JJ; Sargeant TJ
    Behav Brain Res; 2018 Jan; 336():177-181. PubMed ID: 28887197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Voluntary Wheel Running Reduces Amyloid-β42 and Rescues Behavior in Aged Tg2576 Mouse Model of Alzheimer's Disease.
    Francis N; Robison LS; Popescu DL; Michaelos M; Hatfield J; Xu F; Zhu X; Davis J; Anderson ME; Anderson BJ; Van Nostrand WE; Robinson JK
    J Alzheimers Dis; 2020; 73(1):359-374. PubMed ID: 31796673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LMN diet, rich in polyphenols and polyunsaturated fatty acids, improves mouse cognitive decline associated with aging and Alzheimer's disease.
    Fernández-Fernández L; Comes G; Bolea I; Valente T; Ruiz J; Murtra P; Ramirez B; Anglés N; Reguant J; Morelló JR; Boada M; Hidalgo J; Escorihuela RM; Unzeta M
    Behav Brain Res; 2012 Mar; 228(2):261-71. PubMed ID: 22119712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study.
    Yau WW; Tudorascu DL; McDade EM; Ikonomovic S; James JA; Minhas D; Mowrey W; Sheu LK; Snitz BE; Weissfeld L; Gianaros PJ; Aizenstein HJ; Price JC; Mathis CA; Lopez OL; Klunk WE
    Lancet Neurol; 2015 Aug; 14(8):804-813. PubMed ID: 26139022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy.
    Shin HK; Jones PB; Garcia-Alloza M; Borrelli L; Greenberg SM; Bacskai BJ; Frosch MP; Hyman BT; Moskowitz MA; Ayata C
    Brain; 2007 Sep; 130(Pt 9):2310-9. PubMed ID: 17638859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vitamin C deficiency in the brain impairs cognition, increases amyloid accumulation and deposition, and oxidative stress in APP/PSEN1 and normally aging mice.
    Dixit S; Bernardo A; Walker JM; Kennard JA; Kim GY; Kessler ES; Harrison FE
    ACS Chem Neurosci; 2015 Apr; 6(4):570-81. PubMed ID: 25642732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brainwide distribution and variance of amyloid-beta deposits in tg-ArcSwe mice.
    Lillehaug S; Syverstad GH; Nilsson LN; Bjaalie JG; Leergaard TB; Torp R
    Neurobiol Aging; 2014 Mar; 35(3):556-64. PubMed ID: 24126157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age, sex, and cerebral microbleeds in EFAD Alzheimer disease mice.
    Cacciottolo M; Morgan TE; Finch CE
    Neurobiol Aging; 2021 Jul; 103():42-51. PubMed ID: 33813349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
    Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
    Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer's disease.
    Balducci C; Frasca A; Zotti M; La Vitola P; Mhillaj E; Grigoli E; Iacobellis M; Grandi F; Messa M; Colombo L; Molteni M; Trabace L; Rossetti C; Salmona M; Forloni G
    Brain Behav Immun; 2017 Feb; 60():188-197. PubMed ID: 27751869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease.
    Singh BK; Vatsa N; Kumar V; Shekhar S; Sharma A; Jana NR
    Hum Mol Genet; 2017 Oct; 26(20):4042-4054. PubMed ID: 29016862
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools.
    Mitani Y; Yarimizu J; Akashiba H; Shitaka Y; Ni K; Matsuoka N
    J Neurochem; 2013 May; 125(3):465-72. PubMed ID: 23240999
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aged Tg2576 mice are impaired on social memory and open field habituation tests.
    Deacon RM; Koros E; Bornemann KD; Rawlins JN
    Behav Brain Res; 2009 Feb; 197(2):466-8. PubMed ID: 18977397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.